MGX

Metagenomi Therapeutics, Inc.

Insider trading activity for Metagenomi Therapeutics, Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

+$18.3K

net buying

Bought(2 · 1 insiders): $23.4K
Sold(3 · 3 insiders): $5.1K

Past 6 months

+$9K

net buying

Bought(2 · 1 insiders): $23.4K
Sold(6 · 3 insiders): $14.4K

Past 12 months

-$9.7K

net selling

Bought(2 · 1 insiders): $23.4K
Sold(13 · 4 insiders): $33.1K

Transaction history

The 44 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Sep 9	Reid Laurence	Director	PBUY	117	$1.18	$138	+0.6%	Open the original filing on SEC.gov
Sep 9	Reid Laurence	Director	PBUY★	19,883	$1.17	$23.3K	—	Open the original filing on SEC.gov
Sep 8	Wein Matthew	See Remarks	SSELL	358	$1.16	$415	-0.3%	Open the original filing on SEC.gov
Sep 8	Irish Jian	See Remarks	SSELL	2,140	$1.16	$2.5K	-0.6%	Open the original filing on SEC.gov
Sep 8	Wapnick Pamela	Chief Financial Officer	SSELL	1,911	$1.16	$2.2K	-0.9%	Open the original filing on SEC.gov
Jun 9	Reid Laurence	Director	AGRANT◆	17,400	—	—	—	Open the original filing on SEC.gov
Jun 9	Eckhardt Juergen	Director	AGRANT◆	21,000	—	—	—	Open the original filing on SEC.gov
Jun 9	Dere Willard H	Director	AGRANT◆	21,000	—	—	—	Open the original filing on SEC.gov
Jun 9	Bjerkholt Eric	Director	AGRANT◆	21,000	—	—	—	Open the original filing on SEC.gov
Jun 5	Wapnick Pamela	Chief Financial Officer	SSELL	2,884	$1.30	$3.7K	-1.4%	Open the original filing on SEC.gov
Jun 5	Wein Matthew	See Remarks	SSELL	558	$1.30	$725	-0.4%	Open the original filing on SEC.gov
Jun 5	Irish Jian	See Remarks	SSELL	3,737	$1.30	$4.9K	-1.0%	Open the original filing on SEC.gov
Apr 1	Wein Matthew	See Remarks	AGRANT◆	68,000	—	—	—	Open the original filing on SEC.gov
Apr 1	Wein Matthew	See Remarks	AGRANT	11,000	—	—	+9.6%	Open the original filing on SEC.gov
Apr 1	Wapnick Pamela	Chief Financial Officer	AGRANT◆	144,000	—	—	—	Open the original filing on SEC.gov
Apr 1	Wapnick Pamela	Chief Financial Officer	AGRANT	24,000	—	—	+12.8%	Open the original filing on SEC.gov
Apr 1	Irish Jian	See Remarks	AGRANT◆	276,000	—	—	—	Open the original filing on SEC.gov
Apr 1	Irish Jian	See Remarks	AGRANT	46,000	—	—	+13.8%	Open the original filing on SEC.gov
Mar 5	Wapnick Pamela	Chief Financial Officer	SSELL	1,581	$1.60	$2.5K	-0.8%	Open the original filing on SEC.gov
Mar 5	Wein Matthew	See Remarks	SSELL	482	$1.60	$771	-0.4%	Open the original filing on SEC.gov
Mar 5	Irish Jian	Chief Executive Officer	SSELL	1,607	$1.60	$2.6K	-0.5%	Open the original filing on SEC.gov
Dec 5, 2025	Thomas Brian C.	Director	SSELL	3,830	$1.77	$6.8K	-0.1%	Open the original filing on SEC.gov
Dec 5, 2025	Wein Matthew	See Remarks	SSELL	199	$1.77	$353	-0.2%	Open the original filing on SEC.gov
Dec 5, 2025	Wapnick Pamela	Chief Financial Officer	SSELL	1,576	$1.77	$2.8K	-0.8%	Open the original filing on SEC.gov
Dec 5, 2025	Irish Jian	Chief Executive Officer	SSELL	1,602	$1.77	$2.8K	-0.3%	Open the original filing on SEC.gov
Dec 5, 2025	Irish Jian	Chief Executive Officer	GGIFT	228,462	—	—	-40.5%	Open the original filing on SEC.gov
Dec 1, 2025	Wapnick Pamela	Chief Financial Officer	AGRANT	120,000	$1.60	$192K	+170.1%	Open the original filing on SEC.gov
Dec 1, 2025	Wein Matthew	See Remarks	AGRANT	96,000	$1.60	$153.6K	+499.2%	Open the original filing on SEC.gov
Dec 1, 2025	Irish Jian	Chief Executive Officer	AGRANT◆	225,000	—	—	—	Open the original filing on SEC.gov
Dec 1, 2025	Irish Jian	Chief Executive Officer	AGRANT	211,000	$1.60	$337.6K	+59.5%	Open the original filing on SEC.gov
Dec 1, 2025	Irish Jian	Chief Executive Officer	AGRANT	37,500	$1.60	$60K	+11.8%	Open the original filing on SEC.gov
Sep 5, 2025	Thomas Brian C.	Director	SSELL	2,701	$1.81	$4.9K	-0.1%	Open the original filing on SEC.gov
Sep 5, 2025	Wapnick Pamela	Chief Financial Officer	SSELL	1,576	$1.81	$2.9K	-2.2%	Open the original filing on SEC.gov
Sep 5, 2025	Wein Matthew	See Remarks	SSELL	199	$1.81	$360	-1.0%	Open the original filing on SEC.gov
Sep 5, 2025	Irish Jian	Chief Executive Officer	SSELL	1,602	$1.81	$2.9K	-0.5%	Open the original filing on SEC.gov
Sep 2, 2025	Reid Laurence	Director	AGRANT◆	42,000	—	—	—	Open the original filing on SEC.gov
Jun 10, 2025	Eckhardt Juergen	Director	AGRANT◆	21,000	—	—	—	Open the original filing on SEC.gov
Jun 10, 2025	Dere Willard H	Director	AGRANT◆	21,000	—	—	—	Open the original filing on SEC.gov
Jun 10, 2025	Bjerkholt Eric	Director	AGRANT◆	8,572	—	—	—	Open the original filing on SEC.gov
Jun 6, 2025	Wein Matthew	See Remarks	SSELL	199	$1.75	$348	-1.2%	Open the original filing on SEC.gov
Jun 6, 2025	Noonberg Sarah B.	Chief Medical Officer	SSELL	5,239	$1.75	$9.2K	-4.6%	Open the original filing on SEC.gov
Jun 6, 2025	Wapnick Pamela	Chief Financial Officer	SSELL	1,576	$1.75	$2.8K	-2.1%	Open the original filing on SEC.gov
Jun 6, 2025	Thomas Brian C.	Chief Executive Officer	SSELL	10,785	$1.75	$18.9K	-0.4%	Open the original filing on SEC.gov
Jun 6, 2025	Irish Jian	See Remarks	SSELL	6,390	$1.75	$11.2K	-2.0%	Open the original filing on SEC.gov

PBUY$138

Reid Laurence · DirectorSep 9

117 sh @ $1.18 · +0.6% own

PBUY★$23.3K

Reid Laurence · DirectorSep 9

19,883 sh @ $1.17

SSELL$415

Wein Matthew · See RemarksSep 8

358 sh @ $1.16 · -0.3% own

SSELL$2.5K

Irish Jian · See RemarksSep 8

2,140 sh @ $1.16 · -0.6% own

SSELL$2.2K

Wapnick Pamela · Chief Financial…Sep 8

1,911 sh @ $1.16 · -0.9% own

AGRANT◆—

Reid Laurence · DirectorJun 9

17,400 sh

AGRANT◆—

Eckhardt Juergen · DirectorJun 9

21,000 sh

AGRANT◆—

Dere Willard H · DirectorJun 9

21,000 sh

AGRANT◆—

Bjerkholt Eric · DirectorJun 9

21,000 sh

SSELL$3.7K

Wapnick Pamela · Chief Financial…Jun 5

2,884 sh @ $1.30 · -1.4% own

SSELL$725

Wein Matthew · See RemarksJun 5

558 sh @ $1.30 · -0.4% own

SSELL$4.9K

Irish Jian · See RemarksJun 5

3,737 sh @ $1.30 · -1.0% own

AGRANT◆—

Wein Matthew · See RemarksApr 1

68,000 sh

AGRANT—

Wein Matthew · See RemarksApr 1

11,000 sh · +9.6% own

AGRANT◆—

Wapnick Pamela · Chief Financial…Apr 1

144,000 sh

AGRANT—

Wapnick Pamela · Chief Financial…Apr 1

24,000 sh · +12.8% own

AGRANT◆—

Irish Jian · See RemarksApr 1

276,000 sh

AGRANT—

Irish Jian · See RemarksApr 1

46,000 sh · +13.8% own

SSELL$2.5K

Wapnick Pamela · Chief Financial…Mar 5

1,581 sh @ $1.60 · -0.8% own

SSELL$771

Wein Matthew · See RemarksMar 5

482 sh @ $1.60 · -0.4% own

SSELL$2.6K

Irish Jian · Chief Executive…Mar 5

1,607 sh @ $1.60 · -0.5% own

SSELL$6.8K

Thomas Brian C. · DirectorDec 5, 2025

3,830 sh @ $1.77 · -0.1% own

SSELL$353

Wein Matthew · See RemarksDec 5, 2025

199 sh @ $1.77 · -0.2% own

SSELL$2.8K

Wapnick Pamela · Chief Financial…Dec 5, 2025

1,576 sh @ $1.77 · -0.8% own

SSELL$2.8K

Irish Jian · Chief Executive…Dec 5, 2025

1,602 sh @ $1.77 · -0.3% own

GGIFT—

Irish Jian · Chief Executive…Dec 5, 2025

228,462 sh · -40.5% own

AGRANT$192K

Wapnick Pamela · Chief Financial…Dec 1, 2025

120,000 sh @ $1.60 · +170.1% own

AGRANT$153.6K

Wein Matthew · See RemarksDec 1, 2025

96,000 sh @ $1.60 · +499.2% own

AGRANT◆—

Irish Jian · Chief Executive…Dec 1, 2025

225,000 sh

AGRANT$337.6K

Irish Jian · Chief Executive…Dec 1, 2025

211,000 sh @ $1.60 · +59.5% own

AGRANT$60K

Irish Jian · Chief Executive…Dec 1, 2025

37,500 sh @ $1.60 · +11.8% own

SSELL$4.9K

Thomas Brian C. · DirectorSep 5, 2025

2,701 sh @ $1.81 · -0.1% own

SSELL$2.9K

Wapnick Pamela · Chief Financial…Sep 5, 2025

1,576 sh @ $1.81 · -2.2% own

SSELL$360

Wein Matthew · See RemarksSep 5, 2025

199 sh @ $1.81 · -1.0% own

SSELL$2.9K

Irish Jian · Chief Executive…Sep 5, 2025

1,602 sh @ $1.81 · -0.5% own

AGRANT◆—

Reid Laurence · DirectorSep 2, 2025

42,000 sh

AGRANT◆—

Eckhardt Juergen · DirectorJun 10, 2025

21,000 sh

AGRANT◆—

Dere Willard H · DirectorJun 10, 2025

21,000 sh

AGRANT◆—

Bjerkholt Eric · DirectorJun 10, 2025

8,572 sh

SSELL$348

Wein Matthew · See RemarksJun 6, 2025

199 sh @ $1.75 · -1.2% own

SSELL$9.2K

Noonberg Sarah B. · Chief Medical…Jun 6, 2025

5,239 sh @ $1.75 · -4.6% own

SSELL$2.8K

Wapnick Pamela · Chief Financial…Jun 6, 2025

1,576 sh @ $1.75 · -2.1% own

SSELL$18.9K

Thomas Brian C. · Chief Executive…Jun 6, 2025

10,785 sh @ $1.75 · -0.4% own

SSELL$11.2K

Irish Jian · See RemarksJun 6, 2025

6,390 sh @ $1.75 · -2.0% own

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

5 of 33 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 59 business days late.

Form 4 filings made after the two-business-day deadline, with the transaction date, the filing date and the number of business days between them.
Traded	Filed	Insider	Past deadline	Largest line	Source
Dec 5, 2025	Mar 8	Irish JianChief Executive Officer	59days · about 3 months	$2.6K	Filing ↗
Sep 5, 2025	Nov 30, 2025	Wapnick PamelaChief Financial Officer	55days · about 3 months	$192K	Filing ↗
Sep 5, 2025	Nov 30, 2025	Thomas Brian C.Director	55days · about 3 months	$4.9K	Filing ↗
Sep 5, 2025	Nov 30, 2025	Wein MatthewSee Remarks	55days · about 3 months	$153.6K	Filing ↗
Sep 5, 2025	Nov 30, 2025	Irish JianChief Executive Officer	55days · about 3 months	$337.6K	Filing ↗

Irish JianChief Executive Officer

59days · about 3 months

Traded Dec 5, 2025 · filed Mar 8Filing ↗

Wapnick PamelaChief Financial Officer

55days · about 3 months

Traded Sep 5, 2025 · filed Nov 30, 2025Filing ↗

Thomas Brian C.Director

55days · about 3 months

Traded Sep 5, 2025 · filed Nov 30, 2025Filing ↗

Wein MatthewSee Remarks

55days · about 3 months

Traded Sep 5, 2025 · filed Nov 30, 2025Filing ↗

Irish JianChief Executive Officer

55days · about 3 months

Traded Sep 5, 2025 · filed Nov 30, 2025Filing ↗

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →